Your browser doesn't support javascript.
loading
Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer.
Ladak, Farah; Chua, Natalie; Lesniak, David; Ghosh, Sunita; Wiebe, Ericka; Yakimetz, Walter; Rajaee, Nikoo; Olson, David; Peiris, Lashan.
Afiliação
  • Ladak F; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Chua N; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Lesniak D; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Ghosh S; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Wiebe E; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Yakimetz W; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Rajaee N; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Olson D; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
  • Peiris L; From the Division of General Surgery, Department of Surgery, University of Alberta, Edmonton, Alta. (Ladak, Chua, Lesniak, Yakimetz, Rajaee, Olson, Peiris); the Alberta Health Services-Cross Cancer Control Institute, Department of Medical Oncology, University of Alberta, Edmonton, Alta. (Ghosh); the
Can J Surg ; 65(1): E89-E96, 2022.
Article em En | MEDLINE | ID: mdl-35135785

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans Idioma: En Revista: Can J Surg Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Female / Humans Idioma: En Revista: Can J Surg Ano de publicação: 2022 Tipo de documento: Article